Paper Agent · Headache and migraine
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).
Fabrizio Vernieri; Claudia Altamura; Nicoletta Brunelli; Carmelina Maria Costa; Cinzia Aurilia; Gabriella Egeo; Luisa Fofi; Valentina Favoni; Giulia Pierangeli; Carlo Lovati; Marco Aguggia; Florindo d'Onofrio; Alberto Doretti; Paola Di Fiore; Cinzia Finocchi; Renata Rao; Francesco Bono; Angelo Ranieri; Maria Albanese; Sabina Cevoli; Piero Barbanti; GARLIT Study Group
Originally published in The journal of headache and pain · 2021-05-03
